Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.
Copyright 2021 NPR
Moderna And Pfizer On Track To Hit Vaccine Production Goals
Facebook Twitter LinkedIn Email